文献速递呼吸危重症与机械通气

高流量氧疗与文丘里面罩预防拔管后低氧患者再插管的随机对照研究

High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

这项多中心随机试验纳入拔管后PaO2:FiO2≤300 mmHg的494例患者,比较高流量鼻氧与文丘里面罩氧疗。结果显示72小时再插管率两组无显著差异(13%对11%),但高流量组需补救无创通气的比例显著更低(72小时8%对17%,28天12%对21%)。

要点

  • 拔管后低氧患者,高流量鼻氧与文丘里面罩的72小时再插管率无显著差异。
  • 高流量鼻氧可显著减少补救无创通气的使用需求。
  • 文丘里面罩组不允许使用高流量氧疗,两组均可应用补救无创通气。

核心结论

  • 拔管后使用文丘里面罩或高流量氧疗的患者再插管率无显著差异。
  • 高流量氧疗可减少补救无创通气的使用频率。

研究设计与样本

  • 多中心随机临床试验,494例拔管后PaO2:FiO2≤300 mmHg患者随机接受高流量或文丘里面罩氧疗。

主要发现

  • 经插管标准验证的492例患者中,72小时再插管率高流量组13%、文丘里面罩组11%(未校正OR 1.26,95%CI 0.70-2.26;P=0.49)。
  • 28天再插管率高流量组21%、文丘里面罩组23%(校正HR 0.89,95%CI 0.60-1.31;P=0.55)。
  • 72小时补救无创通气需求高流量组8%对文丘里面罩组17%(校正HR 0.39,95%CI 0.22-0.71;P=0.002)。
  • 28天补救无创通气需求高流量组12%对文丘里面罩组21%(校正HR 0.52,95%CI 0.32-0.83;P=0.007)。

关键数值与推荐

  • 主要结局为72小时内按预设标准判定的再插管率,经独立裁定委员会事后验证。
  • 文丘里面罩组不允许使用高流量氧疗,两组均可在再插管前应用补救无创通气。

临床怎么用

  • 拔管后低氧患者选择高流量氧疗虽未降低再插管率,但可减少补救无创通气的使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: When compared with VenturiMask after extubation, high-flow nasal oxygen provides physiological advantages. Objectives: To establish whether high-flow oxygen prevents endotracheal reintubation in hypoxemic patients after extubation, compared with VenturiMask. Methods: In this multicenter randomized trial, 494 patients exhibiting PaO2:FiO2 ratio ⩽ 300 mm Hg after extubation were randomly assigned to receive high-flow or VenturiMask oxygen, with the possibility to apply rescue noninvasive ventilation before reintubation. High-flow use in the VenturiMask group was not permitted. Measurements and Main Results: The primary outcome was the rate of reintubation within 72 hours according to predefined criteria, which were validated a posteriori by an independent adjudication committee. Main secondary outcomes included reintubation rate at 28 days and the need for rescue noninvasive ventilation according to predefined criteria. After intubation criteria validation (n = 492 patients), 32 patients (13%) in the high-flow group and 27 patients (11%) in the VenturiMask group required reintubation at 72 hours (unadjusted odds ratio, 1.26 [95% confidence interval (CI), 0.70-2.26]; P = 0.49). At 28 days, the rate of reintubation was 21% in the high-flow group and 23% in the VenturiMask group (adjusted hazard ratio, 0.89 [95% CI, 0.60-1.31]; P = 0.55). The need for rescue noninvasive ventilation was significantly lower in the high-flow group than in the VenturiMask group: at 72 hours, 8% versus 17% (adjusted hazard ratio, 0.39 [95% CI, 0.22-0.71]; P = 0.002) and at 28 days, 12% versus 21% (adjusted hazard ratio, 0.52 [95% CI, 0.32-0.83]; P = 0.007). Conclusions: Reintubation rate did not significantly differ between patients treated with VenturiMask or high-flow oxygen after extubation. High-flow oxygen yielded less frequent use of rescue noninvasive ventilation. Clinical trial registered with www.clinicaltrials.gov (NCT02107183).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Maggiore SM, Jaber S, Grieco DL, et al. High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial. Am J Respir Crit Care Med. 2022. PMID: 35849787. doi:10.1164/rccm.202201-0065OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。